ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Start-ups

Synthego raises $110 million for CRISPR service offering

by Ryan Cross
October 28, 2018 | APPEARED IN VOLUME 96, ISSUE 43

 

Synthego, a start-up that sells CRISPR gene-editing tool kits and CRISPR-edited cells to researchers, raised $110 million in series C financing last week from the venture capital firms Founders Fund, 8VC, and Menlo Ventures. The start-up is using automation and machine learning to quickly scale up the production of customized CRISPR kits and engineered cells. Chief Operating Officer Ted Tisch says Synthego’s goal is to help lower the cost of cell and gene therapies from hundreds of thousands of dollars to thousands of dollars.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment